Corcept Therapeutics · 3 days ago
Digital Marketing Intern
Corcept Therapeutics is a leader in the research and development of cortisol modulators, dedicated to advancing treatment possibilities for serious diseases. The Digital Marketing Intern will focus on digital and media marketing to enhance customer experiences and support marketing strategies across various channels.
BiotechnologyMedicalPharmaceutical
Responsibilities
Contribute to the overall digital and omnichannel marketing transformation and vision
Partner with the head of digital and omnichannel marketing, and other marketing team members, to translate marketing objectives into integrated, omnichannel marketing strategies and execute tactics that support and drive the business goals of our brand(s) and organization
Liaison between marketing, cross-functional partners and external agencies on digital and omnichannel marketing strategy and ensure effective end-to-end execution
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Qualification
Required
Excellent communication and collaboration skills, with the ability to work effectively across cross-functional teams
Ability to flex and thrive in an ambiguous environment undergoing transformational change
Strong analytical skills to effectively interpret and utilize quantitative and qualitative data to shape strategies and tactics
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Experience working in digital/software marketing, digital production, marketing technology or marketing operations
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Recent News
Genetic Engineering News
2026-01-05
2026-01-03
Company data provided by crunchbase